Donepezil HCl CAS #: 120011-70-3 Donepezil HCl was first approved in the US by the FDA in 1983. It’s since seen tremendous success with the branded version of the API (Aricept) becoming the number-one selling medication for treatment of Alzheimer’s since 2011. According to current data, the brand is still very strong, worth close to[…]
Donepezil HCl – Alleviating Dementia Symptoms
Anti-Alzheimer's, Antidimentia Tags: Alzheimers diseaseDementiaDonepezil Dec 20, 2018
Treatments Available for Surge of Alzheimer’s Cases
Anti-Alzheimer's, Antidimentia, Drug Research & Development API Tags: 120014-06-441100-52-1acetylcholineAlzheimers diseaseDonepezilMemantine Jul 02, 2013
The approval of Aricept fifteen years ago was the last time there was anything new to treat the symptoms of Alzheimer’s disease. This lack of research and drug development is unnerving to patients and practitioners alike, with this lethal disease affecting 5.4 million Americans. On June 13, 2013 the BCC posted an alarming research report,[…]
Alzheimers Disease Is The Fastest Growing Health Threat To Americans
Anti-Alzheimer's, Antidimentia Tags: 120014-06-441100-52-1acetylcholineAlzheimers diseaseDonepezilMemantine Mar 12, 2013
Estimated Number of Cases of AD in the U.S. (millions). A report issued from the University of Washington in Seattle on March 5, 2013 revealed a startling statistic. The fastest growing health threat to Americans is not cancer or heart disease – it is Alzheimers disease! While this may not have been surprising information to[…]
Cases of Dementia and Alzheimer's Disease Rising, Memantine is a Viable Treatment
Antiparkinson Agent, Drug Research & Development API Tags: 41100-52-1Alzheimers diseaseDonepezilMemantine Jun 13, 2012
Memantine Hydrochloride, CAS number 41100-52-1, is an effective oral medication for treating patients with Alzheimer’s disease. LGM Pharma can provide the Memantine Hydrochloride TEVA API for compounding purposes in the US, and offers a full range of support and services to it’s clients. Memantine is the first in a new and formidable class of Alzheimer’s[…]
Donepezil Showing Efficacy for Alzheimer's Disease and Lewy body Dementia
Bulk Active Ingredient, Drug Research & Development API Tags: 120014-06-4acetylcholineAlzheimers diseaseDonepezil Mar 07, 2012
Donepezil, CAS number 120014-06-4, is also marketed under the brand name Aricept, and is used in treatment of Alzheimer’s disease. Patients with dementia have low levels of the brain chemical acetylcholine, which is a crucial chemical for thinking and memory issues. Donepezil improves the patient’s nerve cell functioning by inhibiting the breakdown of acetylcholine. Aricept,[…]